Neoepitopes derived from indels and fusion proteins of AML patients, such as mutated NPM1 and CBFB-MYH11, have also been found to be recognized by T cells from healthy donors in several studies [53, 62]. This evidence concerns the gene MYH11 and acute myeloid leukemia.